PT - JOURNAL ARTICLE AU - Qin, Chunlin AU - Jiang, Nian AU - Tang, Guorong AU - Zhou, Yun AU - Liang, Qingqing TI - A Cross-Sectional Study on HPV Vaccine Awareness, Vaccination Willingness and Associated Factors among Male Healthcare Workers in Ethnic Minority-populated Areas in Southern China AID - 10.1101/2024.09.02.24312968 DP - 2024 Jan 01 TA - medRxiv PG - 2024.09.02.24312968 4099 - http://medrxiv.org/content/early/2024/09/04/2024.09.02.24312968.short 4100 - http://medrxiv.org/content/early/2024/09/04/2024.09.02.24312968.full AB - Introduction Human papillomavirus (HPV) is a common sexually transmitted disease (STD) with a very high prevalence in the male population, resulting in an increasing burden of HPV-related diseases. HPV vaccines are the most effective measure to control HPV infection. However, male HPV vaccine has not been approved for mainland China.Objective To assess awareness, willingness and associated factors of the HPV vaccine among male healthcare workers in ethnic minority-populated areas in southern China. To provide a reference basis for the formulation of promotion strategy for male HPV vaccine after its approval in mainland China.Methods A web-based questionnaire survey on the awareness and willingness to receive HPV vaccine among male healthcare workers in the surveyed areas was conducted using a convenience sampling method, and chi-square test or Fisher’ s exact test and logistic regression analyses were used to analyze and explore the associated factors.Results Respondents’ HPV vaccine awareness and willingness to vaccinate were 74.55% (1,066/1,430) and 80.94% (1,087/1,343, exclusion of vaccinated respondents) respectively. Respondents aged 30∼44 and ≥ 45, intermediate title, and per capita monthly household income of CNY 3,000∼4,000 were discovered to have a correlation with awareness of HPV vaccine (all p<0.05). While, technicians and other occupations (excluding doctors and nurses), with a position, senior title, and ware of HPV vaccine were discovered to have a correlation with willingness to vaccinate (all p<0.05). The belief that the vaccine can prevent HPV infection was the main reason for participants’ willing to get HPV vaccine (91.48% 1,074/1,174). while, believing that they are not at risk of contracting HPV and the high price of HPV vaccine are major barriers to increasing willingness to vaccinate. The most important motivation that could promote receiving the vaccine was the provision of information on the efficacy and safety of the HPV vaccine.Conclusions Male healthcare workers have a high awareness of HPV vaccine and a high willingness of for HPV vaccination in the surveyed areas. Strengthening health education, including HPV vaccine in immunization programmes or health insurance subsidies, and lowing the cost of vaccination will help increase their willingness for HPV vaccination.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The present study was conducted in accordance with the guidelines of the Declaration of Helsinki. The Ethics Committee of Guilin Centre for Disease Control and Prevention provided the necessary ethical approval, Ref No GLCDC-Medical Ethics-202306 with the date 26/07/23.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets involved in the current study are not publicly available due to privacy but are available from the author Chunlin Qin on reasonable request.